A clinical trial to study the effectiveness of fully immersive virtual reality and cognitive training on global cognition,quality of life,iadls and brain activities in patients with mild to moderate Alzheimers disease
Phase 2
- Conditions
- Health Condition 1: G300- Alzheimers disease with early onset
- Registration Number
- CTRI/2024/04/065623
- Lead Sponsor
- Reena Kumari
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients older than 60 years with diagnosis of AD, consent in participation,absence of vision and hearing impairment likely to effect social life,ability to read and write
Exclusion Criteria
1)Patients who have major neurological or psychiatric conditions that may affect cognition (e.g., Parkinson’s disease, Stroke, Schizophrenia)
2)Patients who are unable to comply with the training regimen
3)Patients with visual, vestibular, and auditory impairments
4)Severe orthopaedic impairments
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Global cognitive function measured using montral cognitive scale <br/ ><br> <br/ ><br>Brain activities measured using Electroencephalogram (EEG) <br/ ><br>Timepoint: at baseline and after 8 weeks
- Secondary Outcome Measures
Name Time Method Activities of Daily Living measured by Instrumental activities of daily living scale (IADLS) <br/ ><br>Quality of Lifemeasured by Quality of Life in Alzheimer’s Disease <br/ ><br>Timepoint: at baseline and after 8 weeks